Long-Term Exposure to Air Pollution Tied to Higher Risk for Dementia
By Lori Solomon HealthDay Reporter

TUESDAY, July 29, 2025 -- Long-term exposure to outdoor air pollution may increase the risk for dementia, according to a review published online July 24 in The Lancet Planetary Health.
Clare B. Best Rogowski, from the University of Cambridge in the United Kingdom, and colleagues conducted a systematic literature review and meta-analysis to assess the link between outdoor air pollution and the risk for dementia.
Based on 32 included studies, the researchers found that a dementia diagnosis was significantly associated with long-term exposure to fine particulate matter (PM2.5; 21 studies, about 24 million people; pooled adjusted hazard ratio [HR] per 5 μg/m3 increase in exposure, 1.08; 95 percent confidence interval [CI], 1.02 to 1.14; I2 = 95 percent); nitrogen dioxide (16 studies, about 17.2 million people; pooled adjusted HR per 10 μg/m3 increase, 1.03; 95 percent CI, 1.01 to 1.05; I2 = 84 percent); and black carbon/PM2.5 absorbance (six studies, about 19.4 million people; pooled adjusted HR per 1 μg/m3 increase, 1.13; 95 percent CI, 1.01 to 1.27; I2 = 97 percent). There was no significant association seen for exposure to nitrogen oxides (five studies, 241,409 people; pooled adjusted HR per 10 μg/m3 increase, 1.05; 95 percent CI, 0.97 to 1.13; I2 = 44 percent); PM10 (four studies, 246,440 people; pooled adjusted HR per 15 μg/m3 increase, 1.52; 95 percent CI, 0.80 to 2.87; I2 = 82 percent); or annual ozone (four studies, 419,972 people; pooled adjusted HR per 45 μg/m3 increase, 0.82; 95 percent CI, 0.35 to 1.92; I2 = 69 percent), with moderate to considerable heterogeneity between studies in these pooled analyses. Overall, the certainty of evidence of studies was moderate.
"Efforts to reduce exposure to these key pollutants are likely to help reduce the burden of dementia on society," Rogowski said in a statement. "Stricter limits for several pollutants are likely to be necessary targeting major contributors such as the transport and industry sectors."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-30 06:00
Read more

- Ritz Peanut Butter Crackers Recalled Over Labeling Mistake
- Low Vitamin D Levels Up Risk for COVID-19 Hospitalization
- FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer
- Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping
- CDC, FDA Warn of Possible Salmonella Risk From Frozen Sprouted Beans
- Common Meds Aren't Linked To Inflammatory Bowel Disease, Study Says
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions